These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 16488371)

  • 1. Nanoscience enables ultrasensitive detection of Alzheimer's biomarker.
    Keating CD
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2263-4. PubMed ID: 15703290
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of Donanemab in Early Symptomatic Alzheimer Disease.
    Pomara N; Imbimbo BP
    JAMA; 2023 Dec; 330(23):2304. PubMed ID: 38112820
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's disease and mild cognitive impairment.
    Davidson M
    Dialogues Clin Neurosci; 2009; 11(2):109. PubMed ID: 19585946
    [No Abstract]   [Full Text] [Related]  

  • 4. Management strategies, medical issues, and pathobiology.
    Lippa RL
    Am J Alzheimers Dis Other Demen; 2008; 23(1):9-11. PubMed ID: 18354816
    [No Abstract]   [Full Text] [Related]  

  • 5. Insights into influences on Alzheimer disease blood biomarkers.
    Fyfe I
    Nat Rev Neurol; 2023 Oct; 19(10):575. PubMed ID: 37658241
    [No Abstract]   [Full Text] [Related]  

  • 6. Predicting Driving Cessation in Alzheimer Disease: Performance Beats Biomarkers.
    Dubinsky RM; Stein AC
    Neurology; 2024 Jun; 102(12):e209523. PubMed ID: 38776521
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of actigraphy in detecting and characterizing the early phases of Alzheimer's disease.
    Winer JR
    Sleep; 2024 May; 47(5):. PubMed ID: 38497688
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
    Hansson O; Zetterberg H; Buchhave P; Londos E; Blennow K; Minthon L
    Lancet Neurol; 2006 Mar; 5(3):228-34. PubMed ID: 16488378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical Amyloid Beta in Cognitively Normal Elderly Adults is Associated with Decreased Network Efficiency within the Cerebro-Cerebellar System.
    Steininger SC; Liu X; Gietl A; Wyss M; Schreiner S; Gruber E; Treyer V; Kälin A; Leh S; Buck A; Nitsch RM; Prüssmann KP; Hock C; Unschuld PG
    Front Aging Neurosci; 2014; 6():52. PubMed ID: 24672483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease.
    Rojo LE; Alzate-Morales J; Saavedra IN; Davies P; Maccioni RB
    J Alzheimers Dis; 2010; 19(2):573-89. PubMed ID: 20110603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.
    Lavretsky H; Siddarth P; Kepe V; Ercoli LM; Miller KJ; Burggren AC; Bookheimer SY; Huang SC; Barrio JR; Small GW
    Am J Geriatr Psychiatry; 2009 Jun; 17(6):493-502. PubMed ID: 19472439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal CSF isoprostane and MRI atrophy in the progression to AD.
    de Leon MJ; Mosconi L; Li J; De Santi S; Yao Y; Tsui WH; Pirraglia E; Rich K; Javier E; Brys M; Glodzik L; Switalski R; Saint Louis LA; Pratico D
    J Neurol; 2007 Dec; 254(12):1666-75. PubMed ID: 17994313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative multiresolution wavelet analysis of ERP spectral bands using an ensemble of classifiers approach for early diagnosis of Alzheimer's disease.
    Polikar R; Topalis A; Green D; Kounios J; Clark CM
    Comput Biol Med; 2007 Apr; 37(4):542-58. PubMed ID: 16989799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for the early diagnosis of Alzheimer's disease.
    de Leon MJ; Klunk W
    Lancet Neurol; 2006 Mar; 5(3):198-9. PubMed ID: 16488371
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances on biological markers in early diagnosis of Alzheimer disease.
    Padovani A; Borroni B; Di Luca M
    Adv Clin Chem; 2005; 39():107-29. PubMed ID: 16013669
    [No Abstract]   [Full Text] [Related]  

  • 16. Biomarkers for Alzheimer's disease. The research advances incrementally, but clinical use is still years away.
    Harv Ment Health Lett; 2010 Nov; 27(5):1-3. PubMed ID: 21218612
    [No Abstract]   [Full Text] [Related]  

  • 17. Are CSF biomarkers ready for prime time as diagnostics for Alzheimer disease? Interview by Rebecca Voelker.
    Holtzman DM
    JAMA; 2010 Nov; 304(17):1887. PubMed ID: 21045090
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neurochemical markers of neurodegeneration in the early diagnosis of Alzheimer's disease, vascular and mixed dementia].
    Uspenskaia OV; Iakhno NN; Belushkina NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(8):36-40. PubMed ID: 20823828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid proteins in the diagnosis of Alzheimer's disease.
    Papaliagkas VT; Tsolaki M; Anogianakis G
    Recent Pat CNS Drug Discov; 2010 Jun; 5(2):172-8. PubMed ID: 20408808
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.